Laboratory diagnostic aspects of drug resistant tuberculosis.
about
Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase methodPotential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamidePhenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.Evaluation of the analytical performance of the Xpert MTB/RIF assay.Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South AfricaSignificance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates.Mycobacterium tuberculosis embB codon 306 mutations confer moderately increased resistance to ethambutol in vitro and in vivo.Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunitiesSequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: Identification of a species-specific pncA mutation in "Mycobacterium canettii" and the reliable and rapid predictor of pyrazinamiMolecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France.Single-nucleotide polymorphisms in Rv2629 are specific for Mycobacterium tuberculosis genotypes Beijing and Ghana but not associated with rifampin resistance.The TB laboratory of the future: macrophage-based selection of XDR-TB therapeutics.Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approachThe Second Zambian National Tuberculosis Drug Resistance survey - a comparison of conventional and molecular methods.Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of mulQuantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation.Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean.Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolatesIn house colorimetric reverse hybridisation assay for detection of the mutation most frequently associated with resistance to isoniazid in Mycobacterium tuberculosis.A rapid culture system uninfluenced by an inoculum effect increases reliability and convenience for drug susceptibility testing of Mycobacterium tuberculosis.
P2860
Q28477917-0AB81648-7C80-4C0B-B16E-64D7C749DE57Q33614112-8C49220A-C007-4D3A-814D-2EFD2E01A0F7Q33836636-342BBE50-630F-4BD3-948C-A9EDB6651F87Q33963553-966876BC-C843-4D9E-8C32-8C9D022BC006Q34041549-3E64F0B0-9E8F-4D81-BA33-330F0D655E3BQ34520274-F7A4D51D-53D2-4251-BA6D-DFE089BF8A19Q34648682-F4B3DF10-9E41-4315-A38C-B652349F1ECEQ35005024-A8143681-A5B3-4BF9-A41D-594E22DE68B5Q35066020-C8B24726-56FC-4BE1-BC5E-58B5227E4D97Q35690487-8658F296-AF09-4D79-B229-659EB591E5D4Q35859945-751AF469-874E-4456-A9C6-0F98AB97E85AQ37051424-EEFEAB3A-41BB-462E-80C7-4A97B8E8240FQ37119027-7BC84FCD-EBD2-4FA1-AE26-FEE7C73F5ABEQ37546819-111429CA-E790-481B-82C7-3334269D0C3DQ39120260-74B86CBC-9D61-4E30-9980-5D93215C9248Q39563375-DFD9DE62-0F13-4604-816C-E7845706B6BCQ39990545-BCE03C78-6079-4F8A-9902-8D5E33CF9E1CQ41072559-673A9982-EB8E-4C2C-A215-DA685E2FB6DDQ41995806-FFCFD31C-05EF-40D4-A8DD-38882D2068D9Q42773182-D43CA32F-ED5B-4120-AF86-73B73E8E733EQ43263582-86AFDF1A-C5EC-4B67-A933-DEAB1773E445Q55227253-2373EB0C-E486-4BA8-A1A2-60E4CD5E043C
P2860
Laboratory diagnostic aspects of drug resistant tuberculosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Laboratory diagnostic aspects of drug resistant tuberculosis.
@ast
Laboratory diagnostic aspects of drug resistant tuberculosis.
@en
type
label
Laboratory diagnostic aspects of drug resistant tuberculosis.
@ast
Laboratory diagnostic aspects of drug resistant tuberculosis.
@en
prefLabel
Laboratory diagnostic aspects of drug resistant tuberculosis.
@ast
Laboratory diagnostic aspects of drug resistant tuberculosis.
@en
P2093
P356
P1476
Laboratory diagnostic aspects of drug resistant tuberculosis.
@en
P2093
Akos Somoskövi
Linda M Parsons
Max Salfinger
Richard Urbanczik
P304
P356
10.2741/1290
P577
2004-09-01T00:00:00Z